Company Overview

Longevity Health Holdings, Inc. is a publicly traded healthcare company listed on the OTC Markets under the ticker XAGE. Based on available public disclosures, the company is positioned within the healthcare services and health and wellness sectors, with an emphasis on solutions intended to support improved health outcomes and quality of life. Publicly available filings indicate that the company has historically pursued business models related to healthcare management and wellness-oriented services; however, detailed, current descriptions of active commercial operations are limited.

The company’s operating history reflects multiple strategic and structural changes, including shifts in business focus and corporate restructuring typical of micro‑cap healthcare holding companies. While management communications reference long-term participation in the growing longevity and healthcare services market, publicly verifiable information regarding sustained revenue-generating operations or clearly defined competitive advantages remains limited. Data inconclusive based on available public sources.

Business Operations

According to recent SEC filings and OTC disclosures, Longevity Health Holdings, Inc. functions primarily as a holding company, with business operations conducted through current or former subsidiaries. Historical disclosures reference healthcare-related service initiatives, but do not consistently provide segment-level financial reporting or detailed descriptions of active operating units.

The company reports domestic operations within the United States, with no independently verified evidence of material international revenue or assets. Information regarding proprietary technologies, long-term customer contracts, or large-scale healthcare delivery platforms cannot be consistently corroborated across multiple independent sources. Data inconclusive based on available public sources.

Strategic Position & Investments

Public filings describe a strategy centered on identifying and developing healthcare-related business opportunities aligned with demographic trends such as aging populations and increased healthcare utilization. Management has periodically stated intentions to pursue acquisitions, strategic partnerships, or new service models; however, completed transactions of material scale are not clearly documented in recent reporting periods.

No major acquisitions, operating subsidiaries, or portfolio companies have been consistently confirmed through both regulatory filings and independent financial reporting. References to emerging healthcare or longevity-focused sectors appear strategic in nature rather than tied to disclosed, revenue-producing investments. Data inconclusive based on available public sources.

Geographic Footprint

Longevity Health Holdings, Inc. is headquartered in the United States, with its regulatory filings reflecting a primarily domestic footprint. There is no verified disclosure of significant physical operations, subsidiaries, or revenue streams outside the U.S.

The company does not report meaningful international market penetration, foreign subsidiaries, or cross-border joint ventures in its most recent publicly available filings. Any international strategic intent has not been substantiated through independently verified operational data. Data inconclusive based on available public sources.

Leadership & Governance

Governance information for Longevity Health Holdings, Inc. is derived from OTC Markets disclosures and SEC filings, which indicate a small executive leadership structure consistent with micro-cap holding companies. Management has articulated a focus on strategic flexibility and long-term value creation within healthcare-related markets, though a clearly documented leadership philosophy is limited.

Key executives identified in public filings include:

• Michael J. Richter – Chief Executive Officer
• Michael J. Richter – Chairman of the Board
• [Additional executive roles] – Data inconclusive based on available public sources

Publicly available information on broader executive depth, independent board composition, or formal governance committees is limited and not consistently corroborated across multiple independent sources.